Nalaganje...

Identification of Novel Trypanosoma cruzi Proteasome Inhibitors Using a Luminescence-Based High-Throughput Screening Assay

Chagas’ disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening condition that has become a global issue. Current treatment is limited to two medicines that require prolonged dosing and are associated with multiple side effects, which often lead to treatment di...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Zmuda, Filip, Sastry, Lalitha, Shepherd, Sharon M., Jones, Deuan, Scott, Alison, Craggs, Peter D., Cortes, Alvaro, Gray, David W., Torrie, Leah S., De Rycker, Manu
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709497/
https://ncbi.nlm.nih.gov/pubmed/31307977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00309-19
Oznake: Označite
Brez oznak, prvi označite!